aluates Reports

$ 0.0

Automative

Global Stem Cells Market Research Report 2026

Published Date: 2026-02-05

Report Code: QYRE-Auto-9Z310

Global Stem Cells Market Size Status and Forecast 2022

BUY CHAPTERS

Global Stem Cells Market Research Report 2026

Code: QYRE-Auto-9Z310

Report

2026-02-05

Pages:160

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

CCBC

Vcanbio

Osiris Therapeutics

NuVasive

Chiesi Pharmaceuticals

Medi post

JCR Pharmaceutical

Molmed

PHARMICELL

ANTEROGEN CO LTD

Takeda (TiGenix)

ViaCord

Esperite

BOYA LIFE

Beike Biotechnology

International Medical

Global Cord Blood Corporation

Beijing Health-Biotech Group

ABMD

Lifecell

CBR

Stem Cells Market Size

The global Stem Cells market was valued at US$ 3712 million in 2025 and is anticipated to reach US$ 7583 million by 2032, at a CAGR of 10.9% from 2026 to 2032.

Stem Cells Market

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).

Market Driver:

The Stem Cells market is driven by increasing research and development in regenerative medicine and the growing demand for innovative treatments for chronic diseases. Stem cell therapy has shown promising results in treating conditions such as neurodegenerative disorders, cardiovascular diseases, and orthopedic injuries. Additionally, advancements in biotechnology, such as induced pluripotent stem cells (iPSCs) and CRISPR-based gene editing, are expanding the potential applications of stem cells in personalized medicine. Government and private sector investments in stem cell research, along with regulatory approvals for new therapies, are further propelling market growth.

Market Challenge:

Despite its potential, the Stem Cells market faces challenges related to ethical concerns, regulatory complexities, and high costs. The use of embryonic stem cells remains controversial, leading to restrictions in certain regions. Additionally, stem cell therapies require stringent regulatory approvals due to safety concerns, including tumor formation and immune rejection risks. The high cost of stem cell treatments and the complexity of large-scale manufacturing also pose barriers to widespread adoption. Overcoming these challenges requires continued research, improved standardization, and policy support to ensure the safe and ethical development of stem cell therapies.

Stem cell industry of the world's major players have Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi - post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen, Takeda (TiGenix), CBR, ViaCord, Esperite, LifeCell, CCBC, VCANBIO, BOYA LIFE, Beike Biotechnology and International Medical, etc, It has a total market share of 45%.

This report delivers a comprehensive overview of the global Stem Cells market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Stem Cells. The Stem Cells market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Stem Cells market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Stem Cells manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Stem Cells Market Report

Report Metric	Details
Report Name	Stem Cells Market
Accounted market size in 2025	US$ 3712 million
Forecasted market size in 2032	US$ 7583 million
CAGR	10.9%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Stem Cell Storage Stem Cell Pharmaceutical and Treatment
Segment by Application	Blood Disease Cancer Autoimmune Disease Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi-post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen, Takeda (TiGenix), CBR, ViaCord, Esperite, LifeCell, CCBC, VCANBIO, BOYA LIFE, Beike Biotechnology, International Medical, Global Cord Blood Corporation, Beijing Health-Biotech Group, ABMD
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Stem Cells companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Stem Cells Market growing?

Ans: The Stem Cells Market witnessing a CAGR of 10.9% during the forecast period 2026-2032.

What is the Stem Cells Market size in 2032?

Ans: The Stem Cells Market size in 2032 will be US$ 7583 million.

What is the Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen, Takeda (TiGenix), CBR, ViaCord, Esperite, LifeCell, CCBC, VCANBIO, BOYA LIFE, Beike Biotechnology, International Medical share in Stem Cells Market?

Ans: Stem cell industry of the world's major players have Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi - post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen, Takeda (TiGenix), CBR, ViaCord, Esperite, LifeCell, CCBC, VCANBIO, BOYA LIFE, Beike Biotechnology and International Medical, etc, It has a total market share of 45%.

Who are the main players in the Stem Cells Market report?

Ans: The main players in the Stem Cells Market are Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi-post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen, Takeda (TiGenix), CBR, ViaCord, Esperite, LifeCell, CCBC, VCANBIO, BOYA LIFE, Beike Biotechnology, International Medical, Global Cord Blood Corporation, Beijing Health-Biotech Group, ABMD

What are the Application segmentation covered in the Stem Cells Market report?

Ans: The Applications covered in the Stem Cells Market report are Blood Disease, Cancer, Autoimmune Disease, Others

What are the Type segmentation covered in the Stem Cells Market report?

Ans: The Types covered in the Stem Cells Market report are Stem Cell Storage, Stem Cell Pharmaceutical and Treatment

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Stem Cells Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Stem Cell Storage

1.2.3 Stem Cell Pharmaceutical and Treatment

1.3 Market by Application

1.3.1 Global Stem Cells Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Blood Disease

1.3.3 Cancer

1.3.4 Autoimmune Disease

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Stem Cells Market Perspective (2021–2032)

2.2 Global Stem Cells Growth Trends by Region

2.2.1 Global Stem Cells Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Stem Cells Historic Market Size by Region (2021–2026)

2.2.3 Stem Cells Forecasted Market Size by Region (2027–2032)

2.3 Stem Cells Market Dynamics

2.3.1 Stem Cells Industry Trends

2.3.2 Stem Cells Market Drivers

2.3.3 Stem Cells Market Challenges

2.3.4 Stem Cells Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Stem Cells Players by Revenue

3.1.1 Global Top Stem Cells Players by Revenue (2021–2026)

3.1.2 Global Stem Cells Revenue Market Share by Players (2021–2026)

3.2 Global Top Stem Cells Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Stem Cells Revenue

3.4 Global Stem Cells Market Concentration Ratio

3.4.1 Global Stem Cells Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Stem Cells Revenue in 2025

3.5 Global Key Players of Stem Cells Head Offices and Areas Served

3.6 Global Key Players of Stem Cells, Products and Applications

3.7 Global Key Players of Stem Cells, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Stem Cells Breakdown Data by Type

4.1 Global Stem Cells Historic Market Size by Type (2021–2026)

4.2 Global Stem Cells Forecasted Market Size by Type (2027–2032)

5 Stem Cells Breakdown Data by Application

5.1 Global Stem Cells Historic Market Size by Application (2021–2026)

5.2 Global Stem Cells Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Stem Cells Market Size (2021–2032)

6.2 North America Stem Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Stem Cells Market Size by Country (2021–2026)

6.4 North America Stem Cells Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Stem Cells Market Size (2021–2032)

7.2 Europe Stem Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Stem Cells Market Size by Country (2021–2026)

7.4 Europe Stem Cells Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Stem Cells Market Size (2021–2032)

8.2 Asia-Pacific Stem Cells Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Stem Cells Market Size by Region (2021–2026)

8.4 Asia-Pacific Stem Cells Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Stem Cells Market Size (2021–2032)

9.2 Latin America Stem Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Stem Cells Market Size by Country (2021–2026)

9.4 Latin America Stem Cells Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Stem Cells Market Size (2021–2032)

10.2 Middle East & Africa Stem Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Stem Cells Market Size by Country (2021–2026)

10.4 Middle East & Africa Stem Cells Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Osiris Therapeutics

11.1.1 Osiris Therapeutics Company Details

11.1.2 Osiris Therapeutics Business Overview

11.1.3 Osiris Therapeutics Stem Cells Introduction

11.1.4 Osiris Therapeutics Revenue in Stem Cells Business (2021–2026)

11.1.5 Osiris Therapeutics Recent Development

11.2 NuVasive

11.2.1 NuVasive Company Details

11.2.2 NuVasive Business Overview

11.2.3 NuVasive Stem Cells Introduction

11.2.4 NuVasive Revenue in Stem Cells Business (2021–2026)

11.2.5 NuVasive Recent Development

11.3 Chiesi Pharmaceuticals

11.3.1 Chiesi Pharmaceuticals Company Details

11.3.2 Chiesi Pharmaceuticals Business Overview

11.3.3 Chiesi Pharmaceuticals Stem Cells Introduction

11.3.4 Chiesi Pharmaceuticals Revenue in Stem Cells Business (2021–2026)

11.3.5 Chiesi Pharmaceuticals Recent Development

11.4 Medi-post

11.4.1 Medi-post Company Details

11.4.2 Medi-post Business Overview

11.4.3 Medi-post Stem Cells Introduction

11.4.4 Medi-post Revenue in Stem Cells Business (2021–2026)

11.4.5 Medi-post Recent Development

11.5 JCR Pharmaceutical

11.5.1 JCR Pharmaceutical Company Details

11.5.2 JCR Pharmaceutical Business Overview

11.5.3 JCR Pharmaceutical Stem Cells Introduction

11.5.4 JCR Pharmaceutical Revenue in Stem Cells Business (2021–2026)

11.5.5 JCR Pharmaceutical Recent Development

11.6 MolMed

11.6.1 MolMed Company Details

11.6.2 MolMed Business Overview

11.6.3 MolMed Stem Cells Introduction

11.6.4 MolMed Revenue in Stem Cells Business (2021–2026)

11.6.5 MolMed Recent Development

11.7 Pharmicell

11.7.1 Pharmicell Company Details

11.7.2 Pharmicell Business Overview

11.7.3 Pharmicell Stem Cells Introduction

11.7.4 Pharmicell Revenue in Stem Cells Business (2021–2026)

11.7.5 Pharmicell Recent Development

11.8 Anterogen

11.8.1 Anterogen Company Details

11.8.2 Anterogen Business Overview

11.8.3 Anterogen Stem Cells Introduction

11.8.4 Anterogen Revenue in Stem Cells Business (2021–2026)

11.8.5 Anterogen Recent Development

11.9 Takeda (TiGenix)

11.9.1 Takeda (TiGenix) Company Details

11.9.2 Takeda (TiGenix) Business Overview

11.9.3 Takeda (TiGenix) Stem Cells Introduction

11.9.4 Takeda (TiGenix) Revenue in Stem Cells Business (2021–2026)

11.9.5 Takeda (TiGenix) Recent Development

11.10 CBR

11.10.1 CBR Company Details

11.10.2 CBR Business Overview

11.10.3 CBR Stem Cells Introduction

11.10.4 CBR Revenue in Stem Cells Business (2021–2026)

11.10.5 CBR Recent Development

11.11 ViaCord

11.11.1 ViaCord Company Details

11.11.2 ViaCord Business Overview

11.11.3 ViaCord Stem Cells Introduction

11.11.4 ViaCord Revenue in Stem Cells Business (2021–2026)

11.11.5 ViaCord Recent Development

11.12 Esperite

11.12.1 Esperite Company Details

11.12.2 Esperite Business Overview

11.12.3 Esperite Stem Cells Introduction

11.12.4 Esperite Revenue in Stem Cells Business (2021–2026)

11.12.5 Esperite Recent Development

11.13 LifeCell

11.13.1 LifeCell Company Details

11.13.2 LifeCell Business Overview

11.13.3 LifeCell Stem Cells Introduction

11.13.4 LifeCell Revenue in Stem Cells Business (2021–2026)

11.13.5 LifeCell Recent Development

11.14 CCBC

11.14.1 CCBC Company Details

11.14.2 CCBC Business Overview

11.14.3 CCBC Stem Cells Introduction

11.14.4 CCBC Revenue in Stem Cells Business (2021–2026)

11.14.5 CCBC Recent Development

11.15 VCANBIO

11.15.1 VCANBIO Company Details

11.15.2 VCANBIO Business Overview

11.15.3 VCANBIO Stem Cells Introduction

11.15.4 VCANBIO Revenue in Stem Cells Business (2021–2026)

11.15.5 VCANBIO Recent Development

11.16 BOYA LIFE

11.16.1 BOYA LIFE Company Details

11.16.2 BOYA LIFE Business Overview

11.16.3 BOYA LIFE Stem Cells Introduction

11.16.4 BOYA LIFE Revenue in Stem Cells Business (2021–2026)

11.16.5 BOYA LIFE Recent Development

11.17 Beike Biotechnology

11.17.1 Beike Biotechnology Company Details

11.17.2 Beike Biotechnology Business Overview

11.17.3 Beike Biotechnology Stem Cells Introduction

11.17.4 Beike Biotechnology Revenue in Stem Cells Business (2021–2026)

11.17.5 Beike Biotechnology Recent Development

11.18 International Medical

11.18.1 International Medical Company Details

11.18.2 International Medical Business Overview

11.18.3 International Medical Stem Cells Introduction

11.18.4 International Medical Revenue in Stem Cells Business (2021–2026)

11.18.5 International Medical Recent Development

11.19 Global Cord Blood Corporation

11.19.1 Global Cord Blood Corporation Company Details

11.19.2 Global Cord Blood Corporation Business Overview

11.19.3 Global Cord Blood Corporation Stem Cells Introduction

11.19.4 Global Cord Blood Corporation Revenue in Stem Cells Business (2021–2026)

11.19.5 Global Cord Blood Corporation Recent Development

11.20 Beijing Health-Biotech Group

11.20.1 Beijing Health-Biotech Group Company Details

11.20.2 Beijing Health-Biotech Group Business Overview

11.20.3 Beijing Health-Biotech Group Stem Cells Introduction

11.20.4 Beijing Health-Biotech Group Revenue in Stem Cells Business (2021–2026)

11.20.5 Beijing Health-Biotech Group Recent Development

11.21 ABMD

11.21.1 ABMD Company Details

11.21.2 ABMD Business Overview

11.21.3 ABMD Stem Cells Introduction

11.21.4 ABMD Revenue in Stem Cells Business (2021–2026)

11.21.5 ABMD Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

CCBC

Vcanbio

Osiris Therapeutics

NuVasive

Chiesi Pharmaceuticals

Medi post

JCR Pharmaceutical

Molmed

PHARMICELL

ANTEROGEN CO LTD

Takeda (TiGenix)

ViaCord

Esperite

BOYA LIFE

Beike Biotechnology

International Medical

Global Cord Blood Corporation

Beijing Health-Biotech Group

ABMD

Lifecell

CBR

List of Tables

Table 1. Global Stem Cells Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Stem Cell Storage

Table 3. Key Players of Stem Cell Pharmaceutical and Treatment

Table 4. Global Stem Cells Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Stem Cells Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Stem Cells Market Size by Region (US$ Million), 2021–2026

Table 7. Global Stem Cells Market Share by Region (2021–2026)

Table 8. Global Stem Cells Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Stem Cells Market Share by Region (2027–2032)

Table 10. Stem Cells Market Trends

Table 11. Stem Cells Market Drivers

Table 12. Stem Cells Market Challenges

Table 13. Stem Cells Market Restraints

Table 14. Global Stem Cells Revenue by Players (US$ Million), 2021–2026

Table 15. Global Stem Cells Market Share by Players (2021–2026)

Table 16. Global Top Stem Cells Players by Tier (Tier 1, Tier 2, and Tier 3), based on Stem Cells Revenue, 2025

Table 17. Ranking of Global Top Stem Cells Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Stem Cells Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Stem Cells, Headquarters and Area Served

Table 20. Global Key Players of Stem Cells, Products and Applications

Table 21. Global Key Players of Stem Cells, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Stem Cells Market Size by Type (US$ Million), 2021–2026

Table 24. Global Stem Cells Revenue Market Share by Type (2021–2026)

Table 25. Global Stem Cells Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Stem Cells Revenue Market Share by Type (2027–2032)

Table 27. Global Stem Cells Market Size by Application (US$ Million), 2021–2026

Table 28. Global Stem Cells Revenue Market Share by Application (2021–2026)

Table 29. Global Stem Cells Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Stem Cells Revenue Market Share by Application (2027–2032)

Table 31. North America Stem Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Stem Cells Market Size by Country (US$ Million), 2021–2026

Table 33. North America Stem Cells Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Stem Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Stem Cells Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Stem Cells Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Stem Cells Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Stem Cells Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Stem Cells Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Stem Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Stem Cells Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Stem Cells Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Stem Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Stem Cells Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Stem Cells Market Size by Country (US$ Million), 2027–2032

Table 46. Osiris Therapeutics Company Details

Table 47. Osiris Therapeutics Business Overview

Table 48. Osiris Therapeutics Stem Cells Product

Table 49. Osiris Therapeutics Revenue in Stem Cells Business (US$ Million), 2021–2026

Table 50. Osiris Therapeutics Recent Development

Table 51. NuVasive Company Details

Table 52. NuVasive Business Overview

Table 53. NuVasive Stem Cells Product

Table 54. NuVasive Revenue in Stem Cells Business (US$ Million), 2021–2026

Table 55. NuVasive Recent Development

Table 56. Chiesi Pharmaceuticals Company Details

Table 57. Chiesi Pharmaceuticals Business Overview

Table 58. Chiesi Pharmaceuticals Stem Cells Product

Table 59. Chiesi Pharmaceuticals Revenue in Stem Cells Business (US$ Million), 2021–2026

Table 60. Chiesi Pharmaceuticals Recent Development

Table 61. Medi-post Company Details

Table 62. Medi-post Business Overview

Table 63. Medi-post Stem Cells Product

Table 64. Medi-post Revenue in Stem Cells Business (US$ Million), 2021–2026

Table 65. Medi-post Recent Development

Table 66. JCR Pharmaceutical Company Details

Table 67. JCR Pharmaceutical Business Overview

Table 68. JCR Pharmaceutical Stem Cells Product

Table 69. JCR Pharmaceutical Revenue in Stem Cells Business (US$ Million), 2021–2026

Table 70. JCR Pharmaceutical Recent Development

Table 71. MolMed Company Details

Table 72. MolMed Business Overview

Table 73. MolMed Stem Cells Product

Table 74. MolMed Revenue in Stem Cells Business (US$ Million), 2021–2026

Table 75. MolMed Recent Development

Table 76. Pharmicell Company Details

Table 77. Pharmicell Business Overview

Table 78. Pharmicell Stem Cells Product

Table 79. Pharmicell Revenue in Stem Cells Business (US$ Million), 2021–2026

Table 80. Pharmicell Recent Development

Table 81. Anterogen Company Details

Table 82. Anterogen Business Overview

Table 83. Anterogen Stem Cells Product

Table 84. Anterogen Revenue in Stem Cells Business (US$ Million), 2021–2026

Table 85. Anterogen Recent Development

Table 86. Takeda (TiGenix) Company Details

Table 87. Takeda (TiGenix) Business Overview

Table 88. Takeda (TiGenix) Stem Cells Product

Table 89. Takeda (TiGenix) Revenue in Stem Cells Business (US$ Million), 2021–2026

Table 90. Takeda (TiGenix) Recent Development

Table 91. CBR Company Details

Table 92. CBR Business Overview

Table 93. CBR Stem Cells Product

Table 94. CBR Revenue in Stem Cells Business (US$ Million), 2021–2026

Table 95. CBR Recent Development

Table 96. ViaCord Company Details

Table 97. ViaCord Business Overview

Table 98. ViaCord Stem Cells Product

Table 99. ViaCord Revenue in Stem Cells Business (US$ Million), 2021–2026

Table 100. ViaCord Recent Development

Table 101. Esperite Company Details

Table 102. Esperite Business Overview

Table 103. Esperite Stem Cells Product

Table 104. Esperite Revenue in Stem Cells Business (US$ Million), 2021–2026

Table 105. Esperite Recent Development

Table 106. LifeCell Company Details

Table 107. LifeCell Business Overview

Table 108. LifeCell Stem Cells Product

Table 109. LifeCell Revenue in Stem Cells Business (US$ Million), 2021–2026

Table 110. LifeCell Recent Development

Table 111. CCBC Company Details

Table 112. CCBC Business Overview

Table 113. CCBC Stem Cells Product

Table 114. CCBC Revenue in Stem Cells Business (US$ Million), 2021–2026

Table 115. CCBC Recent Development

Table 116. VCANBIO Company Details

Table 117. VCANBIO Business Overview

Table 118. VCANBIO Stem Cells Product

Table 119. VCANBIO Revenue in Stem Cells Business (US$ Million), 2021–2026

Table 120. VCANBIO Recent Development

Table 121. BOYA LIFE Company Details

Table 122. BOYA LIFE Business Overview

Table 123. BOYA LIFE Stem Cells Product

Table 124. BOYA LIFE Revenue in Stem Cells Business (US$ Million), 2021–2026

Table 125. BOYA LIFE Recent Development

Table 126. Beike Biotechnology Company Details

Table 127. Beike Biotechnology Business Overview

Table 128. Beike Biotechnology Stem Cells Product

Table 129. Beike Biotechnology Revenue in Stem Cells Business (US$ Million), 2021–2026

Table 130. Beike Biotechnology Recent Development

Table 131. International Medical Company Details

Table 132. International Medical Business Overview

Table 133. International Medical Stem Cells Product

Table 134. International Medical Revenue in Stem Cells Business (US$ Million), 2021–2026

Table 135. International Medical Recent Development

Table 136. Global Cord Blood Corporation Company Details

Table 137. Global Cord Blood Corporation Business Overview

Table 138. Global Cord Blood Corporation Stem Cells Product

Table 139. Global Cord Blood Corporation Revenue in Stem Cells Business (US$ Million), 2021–2026

Table 140. Global Cord Blood Corporation Recent Development

Table 141. Beijing Health-Biotech Group Company Details

Table 142. Beijing Health-Biotech Group Business Overview

Table 143. Beijing Health-Biotech Group Stem Cells Product

Table 144. Beijing Health-Biotech Group Revenue in Stem Cells Business (US$ Million), 2021–2026

Table 145. Beijing Health-Biotech Group Recent Development

Table 146. ABMD Company Details

Table 147. ABMD Business Overview

Table 148. ABMD Stem Cells Product

Table 149. ABMD Revenue in Stem Cells Business (US$ Million), 2021–2026

Table 150. ABMD Recent Development

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

Table 154. Authors List of This Report

List of Figures

Figure 1. Stem Cells Picture

Figure 2. Global Stem Cells Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Stem Cells Market Share by Type: 2025 vs 2032

Figure 4. Stem Cell Storage Features

Figure 5. Stem Cell Pharmaceutical and Treatment Features

Figure 6. Global Stem Cells Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Stem Cells Market Share by Application: 2025 vs 2032

Figure 8. Blood Disease Case Studies

Figure 9. Cancer Case Studies

Figure 10. Autoimmune Disease Case Studies

Figure 11. Others Case Studies

Figure 12. Stem Cells Report Years Considered

Figure 13. Global Stem Cells Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Stem Cells Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Stem Cells Market Share by Region: 2025 vs 2032

Figure 16. Global Stem Cells Market Share by Players in 2025

Figure 17. Global Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Stem Cells Revenue in 2025

Figure 19. North America Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Stem Cells Market Share by Country (2021–2032)

Figure 21. United States Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Stem Cells Market Share by Country (2021–2032)

Figure 25. Germany Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Stem Cells Market Share by Region (2021–2032)

Figure 33. China Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Stem Cells Market Share by Country (2021–2032)

Figure 41. Mexico Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Stem Cells Market Share by Country (2021–2032)

Figure 45. Israel Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Osiris Therapeutics Revenue Growth Rate in Stem Cells Business (2021–2026)

Figure 49. NuVasive Revenue Growth Rate in Stem Cells Business (2021–2026)

Figure 50. Chiesi Pharmaceuticals Revenue Growth Rate in Stem Cells Business (2021–2026)

Figure 51. Medi-post Revenue Growth Rate in Stem Cells Business (2021–2026)

Figure 52. JCR Pharmaceutical Revenue Growth Rate in Stem Cells Business (2021–2026)

Figure 53. MolMed Revenue Growth Rate in Stem Cells Business (2021–2026)

Figure 54. Pharmicell Revenue Growth Rate in Stem Cells Business (2021–2026)

Figure 55. Anterogen Revenue Growth Rate in Stem Cells Business (2021–2026)

Figure 56. Takeda (TiGenix) Revenue Growth Rate in Stem Cells Business (2021–2026)

Figure 57. CBR Revenue Growth Rate in Stem Cells Business (2021–2026)

Figure 58. ViaCord Revenue Growth Rate in Stem Cells Business (2021–2026)

Figure 59. Esperite Revenue Growth Rate in Stem Cells Business (2021–2026)

Figure 60. LifeCell Revenue Growth Rate in Stem Cells Business (2021–2026)

Figure 61. CCBC Revenue Growth Rate in Stem Cells Business (2021–2026)

Figure 62. VCANBIO Revenue Growth Rate in Stem Cells Business (2021–2026)

Figure 63. BOYA LIFE Revenue Growth Rate in Stem Cells Business (2021–2026)

Figure 64. Beike Biotechnology Revenue Growth Rate in Stem Cells Business (2021–2026)

Figure 65. International Medical Revenue Growth Rate in Stem Cells Business (2021–2026)

Figure 66. Global Cord Blood Corporation Revenue Growth Rate in Stem Cells Business (2021–2026)

Figure 67. Beijing Health-Biotech Group Revenue Growth Rate in Stem Cells Business (2021–2026)

Figure 68. ABMD Revenue Growth Rate in Stem Cells Business (2021–2026)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Progenitor Cell Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Stem Cell Research Antibodies Market Research Report 2024

Mesenchymal Stem Cells Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mouse Embryonic Stem Cell Market Research Report 2024

Global Stem Cell and Primary Cell Culture Medium Market Insights Forecast to 2030

Global Human Embryonic Stem Cells HESC Market Research Report 2024

Adipose Tissue Derived Stem Cell Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cardiology Stem Cells Market Research Report 2024

Stem Cell Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Stem Cell Characterization Kits Market Research Report 2024

Global Neural Stem Cell Media Market Research Report 2024

Placental Stem Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Stem Cell Reconstructive Market Research Report 2024

Stem Cell Storage Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neural Stem Cell Media and Reagents Market Research Report 2024

Global Stem Cell Beauty Product Market Research Report 2024

Global Stem Cells Storage Market Research Report 2025

Global Stem Cells Storage Services Market Research Report 2025

Global Stem Cell Therapy for Osteoarthritis Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions